Clinical Trial Update: Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib [Phase 2]

View source ↗

Summary

Phase 2 trial assessing fludarabine phosphate with total-body irradiation followed by donor peripheral blood stem cell transplant in adults and children with AL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Myelogenous Leukemia Bcr-abl1 Positive

Drugs mentioned

• Fludarabine phosphate (Fludarabine phosphate)
• Total Body Irradiation

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Phase 2 | Status: COMPLETED | Results posted: 2017-08-22